Sofosbuvir Plus Ledipasvir Treatment in Patients withHepatitis C Genotype 4d Infection who PreviouslyFailed to Achieve Sustained Virological Response withTelaprevir or Boceprevir Combination Therapies

AYGEN B., YILDIZ O., GÖKAHMETOĞLU S., BALTACI S.

Austin Pharmacology Pharmaceutics, vol.3, no.1, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 3 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.1016/j.jfma.2017.06.007
  • Journal Name: Austin Pharmacology Pharmaceutics
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
  • Keywords: Boceprevir, HBV, HCV, Taiwan
  • Erciyes University Affiliated: Yes